异维A酸胶囊联合丹参酮胶囊治疗中重度痤疮的疗效观察

发布时间：2018-01-06 10:26

本文关键词：异维A酸胶囊联合丹参酮胶囊治疗中重度痤疮的疗效观察　出处：《中华疾病控制杂志》2016年07期 　论文类型：期刊论文

【摘要】：目的探讨异维A酸胶囊联合丹参酮胶囊治疗中重度寻常型痤疮的临床疗效分析。方法将102例中重度痤疮患者随机分为治疗组52例和对照组50例,两组分别予以异维A酸胶囊联合丹参酮胶囊以及异维A酸胶囊治疗。结果治疗组中总有效率为67.3%,对照组中总有效率为42.0%,治疗组和对照组间临床疗效比较差异具有统计学意义(χ~2=6.59,P=0.010);与治疗前相比,治疗组临床皮损类型明显好转(均有P0.05)。结论异维A酸胶囊联合丹参酮胶囊口服治疗中重度痤疮临床效果较肯定,可作为临床上中重度痤疮治疗的选择用药。
[Abstract]:Objective to investigate the clinical efficacy of isotinic acid capsule combined with tanshinone capsule in the treatment of moderate and severe acne vulgaris. Methods 102 patients with moderate and severe acne were randomly divided into treatment group (n = 52) and control group (n = 50). The two groups were treated with isotinic acid capsule combined with tanshinone capsule and isotinic acid capsule respectively. Results the total effective rate was 67.3 in the treatment group and 42.0% in the control group. The difference of clinical effect between the treatment group and the control group was statistically significant (蠂 ~ (2 +) 6.59). Compared with before treatment, the types of clinical lesions in the treatment group were obviously improved (P 0.05). Conclusion Isoretinoic acid capsule combined with tanshinone capsule oral treatment of moderate and severe acne clinical effect is more positive. It can be used in the treatment of moderate and severe acne.
【作者单位】：安徽医科大学附属巢湖医院皮肤科;
【分类号】：R758.733
【正文快照】： 寻常型痤疮是毛囊皮脂腺单位的一种多因素疾病。临床表现从轻度的粉刺型痤疮到暴发型伴有系统性症状的痤疮。该病面部为好发部位,虽然所有年龄组都可患此病,但它主要好发于青少年,尤以青春期发病率最高(约85%为12~24岁的年轻人),具有损容性,严重影响患者心理健康。该病病因复

【相似文献】